至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

A Gold(I) Complex Containing an Oleanolic Acid Derivative as a Potential Anti-ovarian Cancer Agent via Inhibiting TrxR and Activating ROS-mediated ERS

Chemistry. 2020; 
Liu W, Bian M, Sun Y, Liu Y, Xu Z, Fan R, Liu Z.
Products/Services Used Details Operation
Molecular Biology Reagents The following primers (GenScript, Nanjing, China) were used: When A2780 cells grew to an abundance of 70 - 80%, treated with different concentrations of 4b for 24 h. Get A Quote

摘要

Many cancer cells critically rely on antioxidant systems for cell survival and are vulnerable to further oxidative impairment triggered by reactive oxygen species (ROS) generating agents. Therefore, the classical design and development of inhibitors that target the antioxidant defense enzymes such as thioredoxin reductase (TrxR) can be a promising anticancer strategy. Here, we show that a gold(I) complex containing an oleanolic acid derivative ( 4b ) induces ovarian cancer (OC) A2780 cells apoptosis by activating the endoplasmic reticulum stress (ERS). It can inhibit TrxR enzyme activity to elevate ROS, mediate ERS and mitochondrial dysfunction, finally leading to the A2780 cells cycle arrest and apoptosis. Not... More

关键词